about
Opioid related nociceptin receptor 1Opioid receptor, kappa 1Opioid receptor, mu 1Opioid receptor-like 1Gastrin releasing peptide receptorGalanin receptor 2Galanin receptor 1Opioid receptor delta 1Neuropeptides B and W receptor 2Melanocortin 4 receptorMelanocortin 3 receptorNeuropeptides B and W receptor 1G protein-coupled receptor 149Somatostatin receptor 3MAS related GPR family member X2ADCYAP receptor type ISomatostatin receptor 2Somatostatin receptor 4Somatostatin receptor 5Somatostatin receptor 1Gastrin-releasing peptide receptor isoform AG protein-coupled receptor 1Prostaglandin D2 receptor 2MAS-related GPR, member B1G protein-coupled receptor 1Somatostatin receptor 1Somatostatin receptor 4G protein-coupled receptor 149Neuropeptides B/W receptor 1Galanin receptor 2Galanin receptor 1Melanocortin 3 receptorMelanocortin 4 receptorMelanin-concentrating hormone receptor 1KISS1 receptorMAS-related GPR, member X2Adenylate cyclase activating polypeptide 1 receptor 1Opioid receptor, delta 1Somatostatin receptor 2Somatostatin receptor 3
P680
Functional analysis of the Ala67Thr polymorphism in agouti related protein associated with anorexia nervosa and leannessMrgX2 is a high potency cortistatin receptor expressed in dorsal root ganglionActivation and functional characterization of the mosaic receptor SorLA/LR11.Ectodomain shedding, translocation and synthesis of SorLA are stimulated by its ligand head activator.The neuropeptide head activator is a high-affinity ligand for the orphan G-protein-coupled receptor GPR37.
P921
Q12746346-BD9329E2-836B-4D10-8FA2-8DBC3F0BC2EEQ14900999-048E410D-4B10-4092-95AC-D786099F6578Q14911929-3E1E2954-41F1-4B6F-AA25-C870028F4B53Q14911986-D2C32479-449B-4B17-889A-92425510567FQ15318428-3935C9F9-EF38-4C78-BF81-CEBDE9A9C5DBQ21110295-4B23851B-BB63-4E91-8EB6-913D7BC9AC4AQ21110304-D97B29A0-BA52-49AA-8CFD-DFAF507362EAQ21115334-4A52EC18-774A-453F-82C1-03A4AF5823E5Q21116887-F8AD2B30-F73C-4A1C-B6EF-1C52ECD467BFQ21118676-2C7805A2-17FB-4330-9392-1C31486A4609Q21118678-E20CC60F-CB13-487D-A852-F10346333732Q21118877-DAA55BB4-8DCA-482E-A604-8C16C5D33272Q21118983-F6268023-16FB-47DE-826C-EFCF780DFC22Q21119483-6CFB9395-E0C9-43B6-9788-9A7EA1D73C3EQ21122415-6BD38340-19DD-47F6-9715-9D4964BD7E9AQ21123675-131B8A60-8773-4540-9058-C5CB3ED224BBQ21126787-B1E48D03-B9D2-42D4-A825-F4497BC9BDB7Q21127277-4A52A7D1-737B-40EF-BD9E-84A7CB7A3117Q21127279-119F2C0C-38C7-44DF-B5E8-A2637CEA3FD2Q21136198-CF8EE22F-287E-44E0-B83A-9A2102F13646Q21149425-B89DFAA7-BE8A-41E0-BFB8-B070B00849FEQ21171761-AAEE5449-FDE2-4C6E-A73E-4FC616F3DF14Q21174141-130E9977-CC0D-42D3-9EDB-6E1928DD9222Q21433578-1643E953-AA17-4042-BD7E-6CA11E463C18Q21494491-28589D1D-7B1C-4FFC-AA7C-B438C4FFF2F4Q21982903-33957941-DD7F-462A-BF6D-BC44262132DAQ21982907-1D9373E7-54A5-4325-A9C8-EA9937241054Q21984869-E56ECEEA-2601-4EF7-BEE5-077E649A6E51Q21985170-DB338AA6-B60C-4F1E-A6A0-F90FF8948F31Q21985371-7F7F5AAD-D6CD-49F1-9C5D-0F820EAEBCD3Q21985372-A55ED2AB-4747-498B-9625-55492D5F5E38Q21986108-8656DE0A-A6CF-4727-A045-890D984A4888Q21986110-D385AF82-3B30-47B9-A7A1-47498D15A716Q21986538-C3BB6E2B-2A53-482D-943E-D27CB8B79802Q21987152-D808165D-F04C-4306-9B30-554A32AE4B91Q21987708-0446C6B7-CD92-4700-B3D6-DB6074C322F1Q21987805-086D1378-73B4-4B59-B740-E0A70C1375ACQ21988386-CDDA5882-F30D-4303-935C-2BE73048902EQ21989203-E96BFB2F-3ED8-42CF-856D-0086F8E3D780Q21989204-FECFF411-4CA8-482A-AB33-5762D9DED1CB
P680
description
Interacting selectively and no ...... tem (peptide neuromodulators).
@en
moleculaire functie
@nl
name
neuropeptide binding
@en
type
label
neuropeptide binding
@en
altLabel
GO:0042923
@en
prefLabel
neuropeptide binding
@en
P279
P2888
P686
GO:0042923